Tag: CBT > CBD FDA: Page 3

Legislation and Regulation

Where is the FDA on CBD?

If the agency began regulating the cannabinoid, per industry members, products would be safer and the market would be more successful.

August 24, 2022

Legislation and Regulation

Industry Professionals Urge Congress to Regulate CBD and Hemp-Derived Compounds in 2023 Farm Bill

USHR Vice President and Kentucky Commissioner of Agriculture noted that the lack of regulation hurts the industry and consumers.

July 29, 2022

Compliance

Study Finds Topical CBD Products Are Often Inaccurately Labeled

John Hopkins Medicine tested 105 topical CBD products and found that less than a fourth were labeled correctly.

July 25, 2022

Future of Hemp Industry

Brightfield Group Estimates US CBD Market Growth Rate Greatly Dependent on FDA Guidance

The report states that FDA officials’ decision on whether to regulate CBD will determine the market’s overall growth rate and its presence in various distribution channels.

July 20, 2022

SAFE Banking Act

‘The Clash Between State and Federal Law in the Cannabis Industry’: 4 Key Takeaways on Federal Policy Reform Efforts

Cozen O’Connor attorneys share insight on where cannabis policy reform might be headed to address the disconnect between federal prohibition and state-legal programs.

June 24, 2022

Compliance

FDA Warns Four Companies for Selling Unapproved Animal Drugs That Contain CBD

The agency said in its warning letters that the drugs, which are intended for use in food-producing animals, violate the Federal Food, Drug, and Cosmetic Act.

May 27, 2022

Hemp Research

New Study Addresses FDA's Concerns, Demonstrates CBD's Safety Profile

The study found that oral consumption of CBD does not negatively impact the liver or cause male reproductive toxicity and drowsiness.

May 19, 2022

Hemp Research

What’s Up With Pet CBD?

As consumer interest in cannabinoids for pets increases, so do questions about capitalizing on the growing market.

May 11, 2022

Compliance

Selling Hemp-Derived Delta-9 THC Products? Here's What to Consider

Marshall Custer of Husch Blackwell law firm dives into legal considerations for hemp businesses selling these products.

May 10, 2022

Interviews & Opinion

FDA Issues First Batch of Warning Letters to Delta-8 THC Product Manufacturers

The federal agency is warning five companies that they are marketing unapproved new drugs, misbranding their wares and unlawfully adding delta-8 THC to food products.

May 6, 2022

CBD Industry

Reflecting on 10 Years in the CBD Industry

The founders of Charlotte’s Web met Charlotte Figi, the company’s namesake, in 2012 and have since witnessed explosive growth in the industry. Now, they’re looking ahead at what’s to come for the company and industry as a whole.

April 8, 2022

Legislation and Regulation

FDA Issues Warning Letters to Companies Claiming Their CBD Products Can Treat COVID-19

The federal agency is warning seven companies that they are falsely advertising their wares.

April 1, 2022